4.6 Editorial Material

Malignant colorectal polyps

Journal

WORLD JOURNAL OF GASTROENTEROLOGY
Volume 16, Issue 25, Pages 3103-3111

Publisher

W J G PRESS
DOI: 10.3748/wjg.v16.i25.3103

Keywords

Favourable histology; Follow-up; Malignant polyps; Non-invasive high grade neoplasia; Treatment

Ask authors/readers for more resources

Nowadays, the number of cases in which malignant colorectal polyps are removed is increasing due to colorectal cancer screening programmes. Cancerous polyps are classified into non-invasive high grade neoplasia (NHGN), when the cancer has not reached the muscularis mucosa, and malignant polyps, classed as T1, when they have invaded the submucosa. NHGN is considered cured with polypectomy, while the prognosis for malignant polyps depends on various morphological and histological factors. The prognostic factors include, sessile or pedunculated morphology of the polyp, whether partial or en bloc resection is carried out, the degree of differentiation of the carcinoma, vascular or lymphatic involvement, and whether the polypectomy resection margin is tumor free. A malignant polyp at T1 is considered cured with polypectomy if it is a pedunculated polyp (Ip of the Paris classification), it has been completely resected, it is not poorly differentiated, the resection edge is not affected by the tumor and there is no vascular or lymphatic involvement. The sessile malignant polyp (Is of the Paris classification) at T1 is considered not cured with polypectomy. Only in some cases (e.g. older people with high surgical risk) local excision (polypectomy or endoscopic submucosal dissection or conventional endoscopic mucosal resection) is considered the definitive treatment. (C) 2010 Baishideng. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)

Olga P. Nyssen, Dino Vaira, Angeles Perez Aisa, Luis Rodrigo, Manuel Castro-Fernandez, Laimas Jonaitis, Bojan Tepes, Liudmila Vologzhanina, Maria Caldas, Angel Lanas, Alfredo J. Lucendo, Luis Bujanda, Juan Ortuno, Jesus Barrio, Jose M. Huguet, Irina Voynovan, Jorge Perez Lasala, Aiman Silkanovna Sarsenbaeva, Luis Fernandez-Salazar, Javier Molina-Infante, Natasa Brglez Jurecic, Miguel Areia, Antonio Gasbarrini, Juozas Kupcinskas, Dmitry Bordin, Ricardo Marcos-Pinto, Frode Lerang, Marcis Leja, Gyorgy M. Buzas, Yaron Niv, Theodore Rokkas, Perminder Phull, Sinead Smith, Oleg Shvets, Marino Venerito, Vladimir Milivojevic, Ilkay Simsek, Vincent Lamy, Peter Bytzer, Lyudmila Boyanova, Lumir Kunovsky, Christoph Beglinger, Michael Doulberis, Wojciech Marlicz, Adrian Goldis, Ante Tonkic, Lisette Capelle, Ignasi Puig, Francis Megraud, Colm O' Morain, Javier P. Gisbert

Summary: The study evaluated the effectiveness and safety of second-line empiric treatment for H pylori infection by European gastroenterologists. For patients who failed previous eradication treatment attempts, treatment regimens including quinolone triple therapies and levofloxacin-bismuth quadruple therapy showed optimal eradication rates.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry

A. Hernandez-Camba, L. Arranz, I Vera, D. Carpio, M. Calafat, A. J. Lucendo, C. Taxonera, S. Marin, M. J. Garcia, G. Suris Marin, E. Sanchez Rodriguez, A. Y. Carbajo, M. L. De Castro, M. Iborra, A. Martin-Cardona, I Rodriguez-Lago, D. Busquets, F. Bertoletti, M. Sierra Ausin, C. Tardillo, J. Huguet Malaves, L. Bujanda, A. Castano, E. Domenech, L. Ramos

Summary: This study evaluated the use of MMF in IBD and found that it has some effectiveness and good safety in treating IBD patients.

DIGESTIVE AND LIVER DISEASE (2022)

Article Gastroenterology & Hepatology

Prevalence of adenomatous polyposis in a fecal immunochemical test-based colorectal cancer screening program and risk of advanced neoplasia during follow-up

Sabela Carballal, Ariadna Sanchez, Leticia Moreira, Jesus Eduardo Cuellar-Monterrubio, Julio Bernuy, Maria Daca, Oswaldo Ortiz, Teresa Ocana, Liseth Rivero-Sanchez, Gerhard Jung, Anna Serradesanferm, Angels Pozo, Jaume Grau, Isabel Tora, Diana Zaffalon, Antoni Castells, Maria Pellise, Francesc Balaguer

Summary: The prevalence of having >= 10 adenomas in a FIT-based CRC screening program was 2.2%. Only a small percentage of patients with >= 20 adenomas had inherited syndromes. The rate of post-colonoscopy CRC was low and the risk of advanced neoplasia decreased throughout follow-up.

ENDOSCOPY (2022)

Article Gastroenterology & Hepatology

Incidence and evolution of foreign body impaction in the upper gastrointestinal tract and its relationship with eosionophilic oesophagitis

Paula Arratibel, Ines Gil-Lasa, Julyssa Cobian, Arantzazu Izagirre-Arostegi, Teresa Arzallus, Ane Etxart, Cristina Sarasqueta, Leire Zubiaurre, Luis Bujanda

Summary: This retrospective study analyzed the clinical data of patients with esophageal foreign body impactions and found that eosinophilic esophagitis (EE) was closely related to factors such as age, history of respiratory diseases, endoscopic findings, and medication use. The study also pointed out a low mortality rate among patients, and deaths were associated with impactions.

GASTROENTEROLOGIA Y HEPATOLOGIA (2022)

Article Medicine, General & Internal

Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg)

Olga P. Nyssen, Dino Vaira, Ilaria Maria Saracino, Giulia Fiorini, Maria Caldas, Luis Bujanda, Rinaldo Pellicano, Alma Keco-Huerga, Manuel Pabon-Carrasco, Elida Oblitas Susanibar, Alfredo Di Leo, Giuseppe Losurdo, Angeles Perez-Aisa, Antonio Gasbarrini, Doron Boltin, Sinead Smith, Perminder Phull, Theodore Rokkas, Dominique Lamarque, Anna Cano-Catala, Ignasi Puig, Francis Megraud, Colm O'Morain, Javier P. Gisbert

Summary: Rifabutin-containing therapy is an effective and safe strategy for Helicobacter pylori eradication, especially after first-line treatment failure or multiple treatment failures.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Biochemistry & Molecular Biology

Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease Severity

Luis G. Guijarro, David Cano-Martinez, M. Val Toledo-Lobo, Lidia Ruiz-Llorente, Maria Chaparro, Ivan Guerra, Marisa Iborra, Jose Luis Cabriada, Luis Bujanda, Carlos Taxonera, Valle Garcia-Sanchez, Ignacio Marin-Jimenez, Manuel Barreiro-de Acosta, Isabel Vera, Maria Dolores Martin-Arranz, Francisco Mesonero, Laura Sempere, Fernando Gomollon, Joaquin Hinojosa, Sofia Zoullas, Jorge Monserrat, Cesar Menor-Salvan, Melchor Alvarez-Mon, Javier P. Gisbert, Miguel A. Ortega, Borja Hernandez-Breijo

Summary: This study found that levels of serum AIF-1 decrease in Crohn's disease (CD) patients after treatment with anti-TNFs. The study also revealed that active CD patients have higher levels of serum AIF-1 compared to inactive CD patients. The combination of serum AIF-1 and CRP levels improves the predictive ability for classifying CD patients by their severity.

BIOMEDICINES (2022)

Article Gastroenterology & Hepatology

A Liquid Biopsy Signature for the Detection of Patients With Early-Onset Colorectal Cancer

Kota Nakamura, Goretti Hernandez, Geeta G. Sharma, Yuma Wada, Jasjit K. Banwait, Natalia Gonzalez, Jose Perea, Francesc Balaguer, Hiroyuki Takamaru, Yutaka Saito, Yuji Toiyama, Yasuhiro Kodera, C. Richard Boland, Luis Bujanda, Enrique Quintero, Ajay Goel

Summary: A circulating miRNA signature has been developed as a potential noninvasive diagnostic tool for early-onset colorectal cancer (EOCRC), with high accuracy and clinical application potential.

GASTROENTEROLOGY (2022)

Article Medicine, General & Internal

Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of Helicobacter pylori Infection (Hp-EuReg)

Luis Fernandez-Salazar, Ana Campillo, Luis Rodrigo, Angeles Perez-Aisa, Jesus M. Gonzalez-Santiago, Xavier Segarra Ortega, Maja Denkovski, Natasa Brglez Jurecic, Luis Bujanda, Blas Jose Gomez Rodriguez, Juan Ortuno, Sotirios Georgopoulos, Laimas Jonaitis, Ignasi Puig, Olga P. Nyssen, Francis Megraud, Colm O'Morain, Javier P. Gisbert

Summary: This study evaluated the decisions and outcomes of H. pylori management by European gastroenterologists through an international multicenter observational registry. The findings suggest that high-dose dual therapy (HDDT) is not a good option for first-line or rescue treatment of H. pylori in Europe, even with the addition of bismuth.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Oncology

Genome-wide methylation profiling identifies a novel gene signature for patients with synchronous colorectal cancer

Yasuyuki Okada, Fuduan Peng, Jose Perea, Luis Corchete, Luis Bujanda, Wei Li, Ajay Goel

Summary: A novel methylation signature risk-scoring model was developed to reliably identify patients with synchronous colorectal cancer (SyCRC), which has the potential to improve the diagnosis and management of colorectal cancer (CRC) patients.

BRITISH JOURNAL OF CANCER (2023)

Article Gastroenterology & Hepatology

Motorized Spiral Enteroscopy Is Effective in Patients with Prior Abdominal Surgery

Antonio Giordano, Gherzon Casanova, Miriam Escapa, Gloria Fernandez-Esparrach, Angels Gines, Oriol Sendino, Isis K. Araujo, Andres Cardenas, Henry Cordova, Julia Martinez-Ocon, Graciela Martinez-Palli, Francesc Balaguer, Josep Llach, Elena Ricart, Begona Gonzalez-Suarez

Summary: Motorized Spiral Enteroscopy (MSE) is an effective and safe examination method for patients with prior major abdominal surgery. Although longer procedure times were observed in these patients, the diagnostic yield was similar. Patients with gastrointestinal surgery showed a lower depth of insertion compared to those with other abdominal surgeries.

DIGESTIVE DISEASES AND SCIENCES (2023)

Article Genetics & Heredity

Germline mutations in WNK2 could be associated with serrated polyposis syndrome

Yasmin Soares de Lima, Coral Arnau-Collell, Jenifer Munoz, Cristina Herrera-Pariente, Leticia Moreira, Teresa Ocana, Marcos Diaz-Gay, Sebastia Franch-Exposito, Miriam Cuatrecasas, Sabela Carballal, Anael Lopez-Novo, Lorena Moreno, Guerau Fernandez, Aranzazu Diaz de Bustamante, Sophia Peters, Anna K. Sommer, Isabel Spier, Iris B. A. W. te Paske, Yasmijn J. van Herwaarden, Antoni Castells, Luis Bujanda, Gabriel Capella, Verena Steinke-Lange, Khalid Mahmood, JiHoon Eric Joo, Julie Arnold, Susan Parry, Finlay A. Macrae, Ingrid M. Winship, Christophe Rosty, Joaquin Cubiella, Daniel Rodriguez-Alcalde, Elke Holinski-Feder, Richarda de Voer, Daniel D. Buchanan, Stefan Aretz, Clara Ruiz-Ponte, Laura Valle, Francesc Balaguer, Laia Bonjoch, Sergi Castellvi-Bel

Summary: Rare germline variants in the WNK2 gene were identified through functional evaluation of a candidate gene and replication in additional SPS cohorts. These variants may affect protein function in the MAPK pathway, thereby increasing the risk for SPS.

JOURNAL OF MEDICAL GENETICS (2023)

Letter Biochemistry & Molecular Biology

A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer

Keisuke Okuno, Raju Kandimalla, Marta Mendiola, Francesc Balaguer, Luis Bujanda, Carlos Fernandez-Martos, Jorge Aparicio, Jaime Feliu, Masanori Tokunaga, Yusuke Kinugasa, Joan Maurel, Ajay Goel

MOLECULAR CANCER (2023)

Article Gastroenterology & Hepatology

A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans

Francisco J. Caballero-Camino, Pedro M. Rodrigues, Fredrik Wangsell, Alona Agirre-Lizaso, Paula Olaizola, Laura Izquierdo-Sanchez, Maria J. Perugorria, Luis Bujanda, Bo Angelin, Sara Straniero, Anna Walleback, Ingemar Starke, Per-Goran Gillberg, Ellen Strangberg, Britta Bonn, Jan P. Mattsson, Martin R. Madsen, Henrik H. Hansen, Erik Lindstrom, Peter Akerblad, Jesus M. Banales

Summary: The ASBT inhibitor A3907 improves cholestatic liver diseases by clearing circulating bile acids and protecting liver function. A3907 targets ASBT in the intestine, liver, and kidney, leading to improved bilirubin and liver injury markers. A3907 is well tolerated in healthy individuals, supporting further clinical development.

HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Prevalence and description of disorders of gut-brain interaction in Spain according to the results of the Rome Foundation Global Epidemiology Study

Joel Flores-Arriaga, Maria C. Aso, Arantzazu Izagirre, Ami D. Sperber, Olafur S. Palsson, Shrikant I. Bangdiwala, Angel Lanas, Luis Bujanda, Beatriz Lobo, Carmen Alonso-Cotoner, Alex Sanchez-Pla, Javier Santos

Summary: The study used data from the Rome Foundation Global Epidemiology Study to assess the prevalence and burden of gut-brain disorders in Spain. The survey, completed by 2072 participants, revealed that 43.6% of respondents met diagnostic criteria for at least one disorder, with functional constipation being the most prevalent. The study highlights the need for specialized training and future research in this area.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Surgery

Familial component of early-onset colorectal cancer: opportunity for prevention

Maria Daca-Alvarez, Marc Marti, Antonino Spinelli, Noel F. F. C. de Miranda, Claire Palles, Alfredo Vivas, Andrew Lachtford, Kevin Monahan, Marek Szczepkowski, Wieslaw Tarnowski, Silviu-Tiberiu Makkai-Popa, Rosario Vidal, Irene Lopez, Elena Hurtado, Fernando Jimenez, Marta Jimenez-Toscano, Edurne Alvaro, Gonzalo Sanz, Araceli Ballestero, Sirio Melone, Lorena Brandariz, Isabel Prieto, Damian Garcia-Olmo, Teresa Ocana, Rebeca Moreira, Lorena Moreno, Sabela Carballal, Leticia Moreira, Maria Pellise, Rogelio Gonzalez-Sarmiento, Andreana N. Holowatyj, Jose Perea, Francesc Balaguer

Summary: This study aimed to explore the impact of family history on preventing early-onset colorectal cancer, finding that the proportion of preventable cases varied based on different guidelines. Early colonoscopy could significantly decrease the incidence of familial early-onset colorectal cancer.

BRITISH JOURNAL OF SURGERY (2022)

No Data Available